查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1997206

膜式氧氣供應市場：2026-2032年全球市場預測（依產品類型、材料、流動配置、溫度、應用和最終用戶分類）

Membrane Oxygenators Market by Product Type, Material, Flow Configuration, Temperature, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，膜氧供應市場價值將達到 7.0416 億美元，到 2026 年將成長至 7.5617 億美元，到 2032 年將達到 11.1433 億美元，年複合成長率為 6.77%。

主要市場統計數據
基準年 2025 7.0416億美元
預計年份：2026年 7.5617億美元
預測年份：2032年 11.1433億美元
複合年成長率 (%) 6.77%

對膜式氧氣輸送系統進行全面概述：涵蓋臨床要求、技術基礎、監管壓力以及相關人員。

膜式氧合系統是體外生命維持和外科灌注的一項基礎技術，它作為血氣交換介面，在心肺體外迴圈手術和長時間體外膜氧合（ECMO）期間維持氧合併清除二氧化碳。其設計、材料以及與監測系統的整合不僅決定了臨床性能，還決定了其可拋棄性、生物相容性和在高壓環境下的易用性。隨著臨床實務朝向更複雜的急診醫學和門診手術發展，氧合裝置的可靠性和可預測性對患者預後仍然至關重要。

材料創新、設備小型化、數位化整合和分散式臨床實踐如何重新定義膜式氧氣輸送設備的設計、製造和採購標準？

在臨床需求、材料科學和系統整合的推動下，膜式氧合技術經歷了變革性的變化。中空纖維結構結合高品質聚甲基戊烯膜和改進的表面塗層，已基本取代了高性能體外循環支持系統中傳統的板式結構，從而提高了氣體交換效率和血液相容性。同時，製造精度和滅菌製程的進步使得一次性氧合器能夠大規模生產，滿足嚴格的無菌性和可追溯性要求，並簡化了手術室的後勤保障。

分析 2025 年美國預期關稅調整對膜氧供應產業相關人員的供應鏈、採購和創新所產生的累積影響。

預計2025年的貿易政策變化和關稅調整將對膜式氧合器的供應鏈、籌資策略和價格趨勢產生重大影響。氧合器高精度製造所需的許多零件和材料都來自跨境供應鏈，進口原料、聚合物樹脂或成品的關稅增加可能會推高製造商和下游買家的收貨成本。這項變更可能會促使供應商和原始設備製造商（OEM）重新審視籌資策略，加快對國內或近岸合作夥伴的供應商認證，並考慮建立本地庫存緩衝，以在貿易環境波動的情況下維持供應的連續性。

細分主導的洞察揭示了設備架構、臨床應用、最終用戶優先級、材料科學、流動配置和熱通訊協定如何相互交織，從而塑造產品策略。

深入的市場細分闡明了產品功能、臨床應用案例和組織採購優先事項如何相互交織，從而塑造需求和創新路徑。按類型分類，市場研究主要集中在平板和中空纖維結構。平板設計在特定的桌上型研究和特殊低流量場景中具有獨特的應用價值，而中空纖維結構則在體外臨床應用中佔據主導地位，因為在這些應用中，表面積體積比和緊湊的外形規格至關重要。從應用角度來看，市場研究主要圍繞著「研究性血液氧合」、「心肺體外迴圈」和「體外膜氧合（ECMO）」。 “研究性血液氧合”進一步細分為“動物實驗”和“體外測試”，這兩者主要驅動材料測試和臨床前性能檢驗。 「心肺體外迴圈」則進一步細分為冠狀動脈繞道手術和瓣膜置換術，這兩種手術都涉及不同的灌注時間曲線和抗凝血管理挑戰。此外，體外膜氧合（ECMO）可進一步分為靜脈-動脈ECMO和靜脈-靜脈ECMO。這反映了不同的血流動力學和氧合需求，這些需求會影響膜的選擇和血流結構。

美洲、歐洲、中東、非洲和亞太市場在臨床應用、監管多樣性和製造能力方面的區域差異，塑造了膜氧供應業務的不同策略。

區域差異影響著臨床實踐、監管流程和採購框架，對製造商和醫療保健系統都具有重大意義。在美洲，領先的體外循環治療機構集中於此，法規環境強調上市後監管和醫療設備可追溯性，供應鏈兼顧國內生產和策略性進口，這些因素共同塑造了臨床應用。這些趨勢為那些擁有可靠的臨床數據、可擴展的生產能力和響應迅速的服務模式的公司創造了商機。

膜氧供應供應商之間的競爭與合作趨勢，重點在於材料創新、智慧財產權定位、生產規模擴大和服務差異化。

膜氧合供應市場的競爭格局呈現出專業製造商、大型醫療設備原始設備製造商 (OEM) 和靈活高效的契約製造的局面。市場領導者和創新新參與企業都在投資於可減少血栓形成的塗層技術、可延長設備使用壽命的膜材料以及可提高批次間一致性的生產過程。醫療設備設計商與臨床研究中心之間的策略合作正在加速實證醫學證據的產生，而與契約製造製造商和包裝專家的合作則有助於更快地擴大生產規模和拓展地域覆蓋範圍。

為了推動永續採用，高階主管需要採取切實可行的、優先的措施來加強供應鏈、加速材料創新、模組化平台和深化臨床夥伴關係。

產業領導者需要實施多方面的措施，以贏得臨床機構的信任、保障利潤率並確保供應的連續性。首先，應盡可能優先考慮供應商多元化和近岸外包，以降低進口關稅和物流波動風險。關鍵原料的雙重採購以及選擇替代聚合物供應商將顯著提高韌性。其次，應加快對聚甲基戊烯加工能力和檢驗的表面處理技術的投資，這些技術能夠有效降低血液相容性風險，因為這些特性正日益成為灌注師和重症監護團隊採購決策中的重要因素。第三，應在產品系列設計中融入模組化理念，使同一核心氧合器平台能夠透過定製配置器和附件套件，滿足冠狀動脈繞道手術術、瓣膜置換術（VA-ECMO）和靜脈-靜脈體外膜肺氧合（VV-ECMO）等不同應用場景的需求。

技術和商業性見解透過嚴格的多模態調查方法檢驗，該方法結合了專家訪談、臨床文獻綜述、監管分析和供應商分析。

本研究採用多層次調查方法，旨在確保研究結果的可重複性、臨床相關性和商業性適用性。主要研究內容包括對臨床醫生、灌注師、採購負責人和生產負責人進行結構化訪談，以了解實際應用中的表現預期、採購限制和營運考慮。次要研究整合了同行評審的臨床文獻、監管文件、醫療設備標籤檢視、專利系列和標準指南，以檢驗技術聲明並建立基準性能標準。供應商資訊分析和生產能力評估結合了公開資訊、行業名錄和現場數據，以確定產能限制和區域生產地點。

整合臨床、技術、監管和供應鏈優先事項的策略結論，指導膜氧合領域穩健、以臨床為中心的決策。

總之，膜氧合系統處於臨床表現、材料工程和供應鏈策略的關鍵交匯點。設計選擇，特別是膜結構、聚合物選擇和表面化學方面的選擇，直接影響心肺體外迴圈、體外膜氧合（ECMO）和研究應用中的臨床結果。監管預期、臨床環境分散化和新的貿易政策的相互作用，要求相關人員採取穩健的籌資策略、有針對性的臨床證據生成和產品模組化，以保持競爭力。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 工業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 膜法制氧市場：依產品類型分類

  • 心肺體外迴圈用氧合器
    • 成人心肺氧化劑
    • 兒童心肺氧化劑
    • 新生兒心肺氧化劑
  • 體外生命維持氧合器
    • 靜脈-動脈體外膜氧合器
    • 靜脈-動脈體外膜氧合器
    • 混合/可配置型體外膜氧合器
  • 整合式氧合器和熱交換器
  • 獨立式氧合器（無熱交換器）

第9章 膜法制氧市場：依材料分類

  • 聚甲基戊烯
  • 聚丙烯
  • 聚碸

第10章 膜式氧氣供應市場：依流量配置分類

  • 封閉式
  • 打開

第11章 以溫度分類的膜法製氧市場

  • 低溫
  • 室溫

第12章 膜法制氧市場：依應用領域分類

  • 用於研究目的的血氧飽和度
    • 動物實驗
    • 體外試驗
  • 心肺體外迴圈
    • 冠狀動脈繞道手術手術
    • 瓣膜置換術
  • 體外膜氧合器（ECMO）
    • 靜脈-動脈體外膜氧合（VaECMO）
    • 靜脈體外膜氧合（ECMO）

第13章 膜法制氧供應市場：依最終用戶分類

  • 門診手術中心
  • 醫院和研究機構

第14章 膜法制氧供應市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章 膜法制氧供應市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章 膜法制氧供應市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章：美國膜法制氧供應市場

第18章：中國膜法制氧供應市場

第19章 競爭情勢

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abbott Laboratories
  • Asahi Kasei Medical Co., Ltd.
  • BRAILE BIOMEDICA INDUSTRIA COMERCIO E REPRESENTACOES LTDA
  • Chalice Medical Ltd
  • CytoSorbents Corporation
  • Dongguan Kewei Medical Instrument Co., Ltd.
  • EUROSETS Srl
  • Fresenius Medical Care AG & Co. KGaA
  • Getinge AB
  • LivaNova PLC
  • Medtronic PLC
  • Merck KGaA
  • MicroPort Scientific Corporation
  • Nikkiso Co., Ltd.
  • Nipro Corporation
  • Senko Medical Instrument Mfg. Co., Ltd.
  • Shandong Weigao Group Medical Polymer Company Limited
  • Terumo Corporation
  • Xenios AG
Product Code: MRR-3E7F10ED1B0D

The Membrane Oxygenators Market was valued at USD 704.16 million in 2025 and is projected to grow to USD 756.17 million in 2026, with a CAGR of 6.77%, reaching USD 1,114.33 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 704.16 million
Estimated Year [2026] USD 756.17 million
Forecast Year [2032] USD 1,114.33 million
CAGR (%) 6.77%

A comprehensive orientation to membrane oxygenators that frames clinical imperatives, technological underpinnings, regulatory pressures, and strategic priorities for industry stakeholders

Membrane oxygenators are a foundational technology in extracorporeal life support and surgical perfusion, serving as the blood-gas exchange interface that sustains oxygenation and carbon dioxide removal during cardiopulmonary bypass procedures and prolonged extracorporeal membrane oxygenation. Their design, materials, and integration with monitoring systems determine not only clinical performance but also disposability, biocompatibility, and ease of use in high-acuity settings. As clinical practice evolves toward more complex critical care applications and ambulatory surgical interventions, oxygenator reliability and predictability remain pivotal to patient outcomes.

Increasingly, clinicians demand devices that balance physiologic performance with operational efficiency. This has driven parallel developments in membrane geometry, fiber fabrication, and surface chemistry to reduce hemolysis, complement activation, and thrombogenicity while maintaining low transmembrane pressure gradients. At the same time, regulatory expectations for single-use devices, sterilization validation, and human factors engineering have sharpened product development priorities. Taken together, these technical and clinical drivers frame the remainder of this executive summary and set the stage for strategic decisions across manufacturing, procurement, and clinical adoption.

How material innovations, device miniaturization, digital integration, and decentralized clinical practice are redefining design, manufacturing, and procurement standards in membrane oxygenation

The membrane oxygenator landscape has undergone transformative shifts driven by clinical need, materials science, and systems integration. Hollow fiber architectures, coupled with advanced polymethylpentene membranes and refined surface coatings, have largely supplanted earlier flat sheet approaches for high-performance extracorporeal support, yielding improvements in gas transfer efficiency and hemocompatibility. Parallel advances in manufacturing fidelity and sterilization processes have enabled scaled production of single-use oxygenators that meet stringent sterility and traceability expectations, while also simplifying operating room logistics.

Concurrently, the clinical environment for these devices is decentralizing. Increased use of extracorporeal membrane oxygenation in nontraditional settings, expansion of ambulatory surgical centers performing complex procedures, and greater reliance on simulation and point-of-care diagnostics have shifted demand toward more modular, user-friendly devices with integrated monitoring. Digital health integration-including real-time sensor telemetry and decision-support algorithms-has enhanced clinician ability to titrate therapy and preempt complications. Sustainability has emerged as a secondary yet growing priority, prompting manufacturers to evaluate lifecycle impacts and to explore recyclable packaging, reduced material footprints, and production waste reduction. Together, these shifts are reshaping development roadmaps, go-to-market strategies, and the criteria by which purchasers evaluate product value.

Analyzing the cumulative supply chain, procurement, and innovation consequences of United States tariff adjustments anticipated in 2025 for membrane oxygenator stakeholders

Anticipated trade policy changes and tariff adjustments in the United States during 2025 carry important implications for membrane oxygenator supply chains, procurement strategies, and price dynamics. Many oxygenator components and high-precision manufacturing inputs originate in cross-border supply chains, and increased duties on imported raw materials, polymer resins, or finished components may elevate landed costs for manufacturers and downstream purchasers. This shift tends to incentivize both suppliers and OEMs to reassess sourcing strategies, accelerate supplier qualification for domestic or nearshore partners, and consider localized inventory buffers to maintain continuity of supply under fluctuating trade conditions.

The cumulative effect of tariff-driven cost pressures often manifests through slower new product introductions and more conservative inventory management in the near term, as manufacturers prioritize margin protection and supply stability. In response, several mitigation pathways are practicable: diversifying the supplier base to reduce single-source exposure; qualifying alternate materials that preserve clinical performance while improving tariff treatment; and implementing contract manufacturing agreements in tariff-favored jurisdictions. For purchasers, longer procurement lead times and revised total-cost-of-ownership calculations will require renewed emphasis on supplier transparency and collaborative forecasting. Ultimately, trade policy is accelerating strategic decisions around vertical integration, supplier partnerships, and design choices that can reduce vulnerability to import duties while sustaining clinical performance standards.

Segmentation-driven insights that reveal how device architecture, clinical application, end-user priorities, material science, flow configuration, and thermal protocols intersect to inform product strategy

Insightful segmentation clarifies how product features, clinical use cases, and organizational purchasing priorities intersect to shape demand and innovation pathways. Based on Type, the market is studied across Flat Sheet and Hollow Fiber architectures; flat sheet designs retain niche applicability for certain bench research and specialized low-flow scenarios, while hollow fiber constructs dominate clinical extracorporeal applications where surface-area-to-volume efficiency and compact form factor matter. In application contexts, the market is studied across Blood Oxygenation For Research, Cardiopulmonary Bypass, and Extracorporeal Membrane Oxygenation. Blood Oxygenation For Research is further studied across Animal Studies and In Vitro Studies, which drive material testing and preclinical performance validation; Cardiopulmonary Bypass is further studied across Coronary Artery Bypass Grafting and Valve Replacement Surgery, both of which impose distinct perfusion time profiles and anticoagulation management challenges; and Extracorporeal Membrane Oxygenation is further studied across Venoarterial ECMO and Venovenous ECMO, reflecting divergent hemodynamic and oxygenation requirements that influence membrane selection and flow architecture.

End user segmentation reveals differing procurement drivers: Ambulatory Surgical Centers, Hospitals, and Research Institutes each evaluate oxygenators through lenses of cost efficiency, clinical robustness, and experimental flexibility, respectively. Based on Material, the market is studied across Polymethylpentene, Polypropylene, and Polysulfone, with polymethylpentene increasingly preferred for long-duration extracorporeal support due to its favorable gas permeability and thermal stability, while polypropylene offers cost advantages in some disposable formats and polysulfone provides broad thermal and chemical resilience. Flow configuration analysis, based on Flow Configuration, examines Closed and Open systems, where closed-loop designs prioritize infection control and precise gas exchange control and open configurations favor simplicity and accessibility for certain surgical workflows. Temperature-driven segmentation, based on Temperature, studies Hypothermic and Normothermic use cases, recognizing that membrane performance and hemocompatibility profiles can differ under altered thermal states and that device validation must address biophysical variability across these clinical protocols. Collectively, these segmentation lenses inform design trade-offs, regulatory strategies, and targeted commercialization approaches.

Regional clinical adoption, regulatory diversity, and manufacturing capacity shape differentiated strategies across the Americas, EMEA, and Asia-Pacific markets for membrane oxygenator businesses

Regional variation influences clinical practices, regulatory pathways, and procurement frameworks in ways that matter for manufacturers and health systems alike. In the Americas, clinical adoption is shaped by concentrated centers of excellence for extracorporeal therapy, a regulatory environment that emphasizes post-market surveillance and device traceability, and supply chains that favor both domestic manufacturing and strategic imports. These dynamics create opportunities for companies that can demonstrate robust clinical data, scalable manufacturing, and responsive service models.

Europe, Middle East & Africa presents a heterogeneous landscape where regulatory harmonization efforts coexist with country-specific procurement norms; reimbursement variability and divergent hospital tender processes require flexible commercialization models and strong clinical affairs engagement. Local manufacturing partnerships and distributor relationships frequently determine market entry speed. Asia-Pacific continues to exhibit rapid clinical adoption in selected urban centers, coupled with an expanding base of local manufacturers and contract producers capable of competing on lead time and cost. Strategic partnerships, technology transfer agreements, and region-specific regulatory strategies are essential to navigate this diverse territory and to align product portfolios with regional clinical and economic priorities.

Competitive and partnership dynamics that highlight material innovation, IP positioning, manufacturing scaling, and service-enabled differentiation among membrane oxygenator providers

Competitive dynamics in the membrane oxygenator landscape are defined by a blend of specialized manufacturers, large medical device OEMs, and nimble contract producers. Market leaders and innovative newcomers alike are investing in coating chemistries that reduce thrombogenic response, in membrane materials that extend functional duration, and in manufacturing processes that improve lot-to-lot consistency. Strategic partnerships between device designers and clinical research centers are accelerating evidence generation, while alliances with contract manufacturers and packaging specialists are enabling faster scale-up and broader geographic reach.

Intellectual property portfolios around hollow fiber geometry, surface treatment processes, and integrated sensor technologies remain strategic assets, and companies that combine strong IP protection with a clear clinical value proposition tend to secure favorable procurement outcomes. Distribution strategies vary, with some firms emphasizing direct hospital relationships and clinical training programs, while others leverage distributor networks to broaden penetration. For many players, the next wave of differentiation will come from demonstrating superior real-world performance, offering integrated clinical support services, and presenting clear pathways for regulatory compliance in key jurisdictions.

Practical and prioritized actions for executives to fortify supply chains, accelerate material innovation, modularize platforms, and deepen clinical partnerships to drive sustainable adoption

Industry leaders must adopt a multi-pronged set of actions to capture clinical trust, protect margins, and ensure supply continuity. First, prioritize supplier diversification and nearshoring where feasible to reduce exposure to import duties and logistics volatility; dual-sourcing critical inputs and qualifying alternate polymer suppliers will materially improve resilience. Second, accelerate investment in polymethylpentene processing capabilities and in validated surface treatments that demonstrably reduce hemocompatibility risks, since these attributes increasingly inform purchasing decisions among perfusionists and critical care teams. Third, design product portfolios with modularity in mind, enabling the same core oxygenator platform to address distinct use cases-such as coronary artery bypass grafting, valve replacement surgery, venoarterial ECMO, and venovenous ECMO-through targeted configurators and accessory kits.

Additionally, expand clinical engagement through structured training programs and outcome-oriented support services that reduce adoption friction in ambulatory surgical centers and community hospitals. Engage proactively with regulatory bodies to align clinical evidence generation with approval pathways and to anticipate changes in sterility and labeling requirements. Finally, adopt transparent total-cost-of-use communication with purchasers, emphasizing device reliability, lifecycle logistics, and post-market support to build durable procurement relationships in an environment of evolving trade policy and reimbursement expectations.

A rigorous multimodal research methodology combining expert interviews, clinical literature review, regulatory analysis, and supplier mapping to validate technical and commercial insights

This research draws on a layered methodology designed to ensure reproducibility, clinical relevance, and commercial applicability. Primary inputs include structured interviews with clinicians, perfusionists, procurement professionals, and manufacturing leaders to capture real-world performance expectations, procurement constraints, and operational considerations. Secondary research synthesizes peer-reviewed clinical literature, regulatory filings, device labeling, patent families, and standards guidance to validate technological claims and to establish baseline performance criteria. Supplier mapping and manufacturing capability assessments combine public filings, industry directories, and site-level intelligence to identify capacity constraints and regional production footprints.

Analytical methods emphasize triangulation: clinical insights inform interpretation of technical specifications, which are then cross-checked against manufacturing feasibility and regulatory precedent. Segmentation analysis uses validated clinical workflows and procurement behaviors to allocate qualitative demand drivers across device types, applications, end users, materials, flow configurations, and temperature protocols. Limitations include variability in country-level procurement practices and the evolving nature of trade policy, which the methodology addresses through scenario-based sensitivity checks and expert validation rounds. Ethical review procedures and confidentiality safeguards were applied during interviews to protect proprietary clinical data and to ensure compliance with research governance norms.

Strategic conclusions synthesizing clinical, technical, regulatory, and supply chain priorities to guide resilient and clinically focused decision-making in membrane oxygenation

In closing, membrane oxygenators occupy a critical nexus of clinical performance, materials engineering, and supply chain strategy. Design choices-particularly around membrane architecture, polymer selection, and surface chemistry-directly influence clinical outcomes across cardiopulmonary bypass, extracorporeal membrane oxygenation, and research applications. The interplay between regulatory expectations, decentralizing clinical settings, and emergent trade policies requires stakeholders to pursue resilient sourcing strategies, targeted clinical evidence generation, and product modularity to remain competitive.

Decision-makers should prioritize investments that align material innovation with manufacturability, while maintaining a sharp focus on clinician usability and post-market surveillance. Regional strategies must be tailored to prevailing regulatory and procurement landscapes, and companies that combine technical excellence with service-enabled offerings will be better positioned to capture long-term clinical trust. By integrating the strategic, clinical, and operational insights outlined here, industry participants can navigate near-term disruptions while advancing safer, more effective oxygenation solutions for patients.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Membrane Oxygenators Market, by Product Type

  • 8.1. Cardiopulmonary Bypass Oxygenators
    • 8.1.1. Adult Cardiopulmonary Oxygenators
    • 8.1.2. Pediatric Cardiopulmonary Oxygenators
    • 8.1.3. Neonatal Cardiopulmonary Oxygenators
  • 8.2. Extracorporeal Life Support Oxygenators
    • 8.2.1. Veno-Arterial ECMO Oxygenators
    • 8.2.2. Veno-Venous ECMO Oxygenators
    • 8.2.3. Hybrid / Configurable ECMO Oxygenators
  • 8.3. Integrated Oxygenator-Heat Exchangers
  • 8.4. Standalone Oxygenators (Without Heat Exchanger)

9. Membrane Oxygenators Market, by Material

  • 9.1. Polymethylpentene
  • 9.2. Polypropylene
  • 9.3. Polysulfone

10. Membrane Oxygenators Market, by Flow Configuration

  • 10.1. Closed
  • 10.2. Open

11. Membrane Oxygenators Market, by Temperature

  • 11.1. Hypothermic
  • 11.2. Normothermic

12. Membrane Oxygenators Market, by Application

  • 12.1. Blood Oxygenation For Research
    • 12.1.1. Animal Studies
    • 12.1.2. In Vitro Studies
  • 12.2. Cardiopulmonary Bypass
    • 12.2.1. Coronary Artery Bypass Grafting
    • 12.2.2. Valve Replacement Surgery
  • 12.3. Extracorporeal Membrane Oxygenation
    • 12.3.1. Venoarterial ECMO
    • 12.3.2. Venovenous ECMO

13. Membrane Oxygenators Market, by End User

  • 13.1. Ambulatory Surgical Centers
  • 13.2. Hospitals & Research Institutes

14. Membrane Oxygenators Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Membrane Oxygenators Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Membrane Oxygenators Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Membrane Oxygenators Market

18. China Membrane Oxygenators Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Abbott Laboratories
  • 19.6. Asahi Kasei Medical Co., Ltd.
  • 19.7. BRAILE BIOMEDICA INDUSTRIA COMERCIO E REPRESENTACOES LTDA
  • 19.8. Chalice Medical Ltd
  • 19.9. CytoSorbents Corporation
  • 19.10. Dongguan Kewei Medical Instrument Co., Ltd.
  • 19.11. EUROSETS S.r.l.
  • 19.12. Fresenius Medical Care AG & Co. KGaA
  • 19.13. Getinge AB
  • 19.14. LivaNova PLC
  • 19.15. Medtronic PLC
  • 19.16. Merck KGaA
  • 19.17. MicroPort Scientific Corporation
  • 19.18. Nikkiso Co., Ltd.
  • 19.19. Nipro Corporation
  • 19.20. Senko Medical Instrument Mfg. Co., Ltd.
  • 19.21. Shandong Weigao Group Medical Polymer Company Limited
  • 19.22. Terumo Corporation
  • 19.23. Xenios AG

LIST OF FIGURES

  • FIGURE 1. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL MEMBRANE OXYGENATORS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL MEMBRANE OXYGENATORS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY FLOW CONFIGURATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY TEMPERATURE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES MEMBRANE OXYGENATORS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA MEMBRANE OXYGENATORS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS OXYGENATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS OXYGENATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS OXYGENATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS OXYGENATORS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY ADULT CARDIOPULMONARY OXYGENATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY ADULT CARDIOPULMONARY OXYGENATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY ADULT CARDIOPULMONARY OXYGENATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY PEDIATRIC CARDIOPULMONARY OXYGENATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY PEDIATRIC CARDIOPULMONARY OXYGENATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY PEDIATRIC CARDIOPULMONARY OXYGENATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY NEONATAL CARDIOPULMONARY OXYGENATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY NEONATAL CARDIOPULMONARY OXYGENATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY NEONATAL CARDIOPULMONARY OXYGENATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL LIFE SUPPORT OXYGENATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL LIFE SUPPORT OXYGENATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL LIFE SUPPORT OXYGENATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL LIFE SUPPORT OXYGENATORS, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY VENO-ARTERIAL ECMO OXYGENATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY VENO-ARTERIAL ECMO OXYGENATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY VENO-ARTERIAL ECMO OXYGENATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY VENO-VENOUS ECMO OXYGENATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY VENO-VENOUS ECMO OXYGENATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY VENO-VENOUS ECMO OXYGENATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY HYBRID / CONFIGURABLE ECMO OXYGENATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY HYBRID / CONFIGURABLE ECMO OXYGENATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY HYBRID / CONFIGURABLE ECMO OXYGENATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY INTEGRATED OXYGENATOR-HEAT EXCHANGERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY INTEGRATED OXYGENATOR-HEAT EXCHANGERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY INTEGRATED OXYGENATOR-HEAT EXCHANGERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY STANDALONE OXYGENATORS (WITHOUT HEAT EXCHANGER), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY STANDALONE OXYGENATORS (WITHOUT HEAT EXCHANGER), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY STANDALONE OXYGENATORS (WITHOUT HEAT EXCHANGER), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY POLYMETHYLPENTENE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY POLYMETHYLPENTENE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY POLYMETHYLPENTENE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY POLYPROPYLENE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY POLYPROPYLENE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY POLYPROPYLENE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY POLYSULFONE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY POLYSULFONE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY POLYSULFONE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY FLOW CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY CLOSED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY CLOSED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY CLOSED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY OPEN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY OPEN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY OPEN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY TEMPERATURE, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY HYPOTHERMIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY HYPOTHERMIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY HYPOTHERMIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY NORMOTHERMIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY NORMOTHERMIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY NORMOTHERMIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY ANIMAL STUDIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY ANIMAL STUDIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY ANIMAL STUDIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY IN VITRO STUDIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY IN VITRO STUDIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY IN VITRO STUDIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY VALVE REPLACEMENT SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY VALVE REPLACEMENT SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY VALVE REPLACEMENT SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY VENOARTERIAL ECMO, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY VENOARTERIAL ECMO, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY VENOARTERIAL ECMO, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY VENOVENOUS ECMO, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY VENOVENOUS ECMO, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY VENOVENOUS ECMO, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY HOSPITALS & RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY HOSPITALS & RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY HOSPITALS & RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS MEMBRANE OXYGENATORS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS MEMBRANE OXYGENATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS OXYGENATORS, 2018-2032 (USD MILLION)
  • TABLE 101. AMERICAS MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL LIFE SUPPORT OXYGENATORS, 2018-2032 (USD MILLION)
  • TABLE 102. AMERICAS MEMBRANE OXYGENATORS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 103. AMERICAS MEMBRANE OXYGENATORS MARKET SIZE, BY FLOW CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 104. AMERICAS MEMBRANE OXYGENATORS MARKET SIZE, BY TEMPERATURE, 2018-2032 (USD MILLION)
  • TABLE 105. AMERICAS MEMBRANE OXYGENATORS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 106. AMERICAS MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 107. AMERICAS MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, 2018-2032 (USD MILLION)
  • TABLE 108. AMERICAS MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 109. AMERICAS MEMBRANE OXYGENATORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS OXYGENATORS, 2018-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL LIFE SUPPORT OXYGENATORS, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY FLOW CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY TEMPERATURE, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 119. NORTH AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, 2018-2032 (USD MILLION)
  • TABLE 120. NORTH AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 124. LATIN AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS OXYGENATORS, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL LIFE SUPPORT OXYGENATORS, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY FLOW CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 128. LATIN AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY TEMPERATURE, 2018-2032 (USD MILLION)
  • TABLE 129. LATIN AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 130. LATIN AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, 2018-2032 (USD MILLION)
  • TABLE 132. LATIN AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 133. LATIN AMERICA MEMBRANE OXYGENATORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE, MIDDLE EAST & AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE, MIDDLE EAST & AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS OXYGENATORS, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE, MIDDLE EAST & AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL LIFE SUPPORT OXYGENATORS, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE, MIDDLE EAST & AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE, MIDDLE EAST & AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY FLOW CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE, MIDDLE EAST & AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY TEMPERATURE, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE, MIDDLE EAST & AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE, MIDDLE EAST & AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE, MIDDLE EAST & AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE, MIDDLE EAST & AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE MEMBRANE OXYGENATORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE MEMBRANE OXYGENATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS OXYGENATORS, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL LIFE SUPPORT OXYGENATORS, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE MEMBRANE OXYGENATORS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE MEMBRANE OXYGENATORS MARKET SIZE, BY FLOW CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE MEMBRANE OXYGENATORS MARKET SIZE, BY TEMPERATURE, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE MEMBRANE OXYGENATORS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE MEMBRANE OXYGENATORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 158. MIDDLE EAST MEMBRANE OXYGENATORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 159. MIDDLE EAST MEMBRANE OXYGENATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. MIDDLE EAST MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS OXYGENATORS, 2018-2032 (USD MILLION)
  • TABLE 161. MIDDLE EAST MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL LIFE SUPPORT OXYGENATORS, 2018-2032 (USD MILLION)
  • TABLE 162. MIDDLE EAST MEMBRANE OXYGENATORS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 163. MIDDLE EAST MEMBRANE OXYGENATORS MARKET SIZE, BY FLOW CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 164. MIDDLE EAST MEMBRANE OXYGENATORS MARKET SIZE, BY TEMPERATURE, 2018-2032 (USD MILLION)
  • TABLE 165. MIDDLE EAST MEMBRANE OXYGENATORS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 166. MIDDLE EAST MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 167. MIDDLE EAST MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, 2018-2032 (USD MILLION)
  • TABLE 168. MIDDLE EAST MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 169. MIDDLE EAST MEMBRANE OXYGENATORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 170. AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 171. AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 172. AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS OXYGENATORS, 2018-2032 (USD MILLION)
  • TABLE 173. AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL LIFE SUPPORT OXYGENATORS, 2018-2032 (USD MILLION)
  • TABLE 174. AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 175. AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY FLOW CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 176. AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY TEMPERATURE, 2018-2032 (USD MILLION)
  • TABLE 177. AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 178. AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 179. AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, 2018-2032 (USD MILLION)
  • TABLE 180. AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 181. AFRICA MEMBRANE OXYGENATORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 182. ASIA-PACIFIC MEMBRANE OXYGENATORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 183. ASIA-PACIFIC MEMBRANE OXYGENATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. ASIA-PACIFIC MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS OXYGENATORS, 2018-2032 (USD MILLION)
  • TABLE 185. ASIA-PACIFIC MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL LIFE SUPPORT OXYGENATORS, 2018-2032 (USD MILLION)
  • TABLE 186. ASIA-PACIFIC MEMBRANE OXYGENATORS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 187. ASIA-PACIFIC MEMBRANE OXYGENATORS MARKET SIZE, BY FLOW CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 188. ASIA-PACIFIC MEMBRANE OXYGENATORS MARKET SIZE, BY TEMPERATURE, 2018-2032 (USD MILLION)
  • TABLE 189. ASIA-PACIFIC MEMBRANE OXYGENATORS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 190. ASIA-PACIFIC MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 191. ASIA-PACIFIC MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, 2018-2032 (USD MILLION)
  • TABLE 192. ASIA-PACIFIC MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 193. ASIA-PACIFIC MEMBRANE OXYGENATORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 194. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 195. ASEAN MEMBRANE OXYGENATORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 196. ASEAN MEMBRANE OXYGENATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 197. ASEAN MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS OXYGENATORS, 2018-2032 (USD MILLION)
  • TABLE 198. ASEAN MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL LIFE SUPPORT OXYGENATORS, 2018-2032 (USD MILLION)
  • TABLE 199. ASEAN MEMBRANE OXYGENATORS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 200. ASEAN MEMBRANE OXYGENATORS MARKET SIZE, BY FLOW CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 201. ASEAN MEMBRANE OXYGENATORS MARKET SIZE, BY TEMPERATURE, 2018-2032 (USD MILLION)
  • TABLE 202. ASEAN MEMBRANE OXYGENATORS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 203. ASEAN MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 204. ASEAN MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, 2018-2032 (USD MILLION)
  • TABLE 205. ASEAN MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 206. ASEAN MEMBRANE OXYGENATORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 207. GCC MEMBRANE OXYGENATORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 208. GCC MEMBRANE OXYGENATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 209. GCC MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS OXYGENATORS, 2018-2032 (USD MILLION)
  • TABLE 210. GCC MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL LIFE SUPPORT OXYGENATORS, 2018-2032 (USD MILLION)
  • TABLE 211. GCC MEMBRANE OXYGENATORS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 212. GCC MEMBRANE OXYGENATORS MARKET SIZE, BY FLOW CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 213. GCC MEMBRANE OXYGENATORS MARKET SIZE, BY TEMPERATURE, 2018-2032 (USD MILLION)
  • TABLE 214. GCC MEMBRANE OXYGENATORS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 215. GCC MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 216. GCC MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, 2018-2032 (USD MILLION)
  • TABLE 217. GCC MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 218. GCC MEMBRANE OXYGENATORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 219. EUROPEAN UNION MEMBRANE OXYGENATORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPEAN UNION MEMBRANE OXYGENATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPEAN UNION MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS OXYGENATORS, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPEAN UNION MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL LIFE SUPPORT OXYGENATORS, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPEAN UNION MEMBRANE OXYGENATORS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPEAN UNION MEMBRANE OXYGENATORS MARKET SIZE, BY FLOW CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPEAN UNION MEMBRANE OXYGENATORS MARKET SIZE, BY TEMPERATURE, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPEAN UNION MEMBRANE OXYGENATORS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 227. EUROPEAN UNION MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 228. EUROPEAN UNION MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, 2018-2032 (USD MILLION)
  • TABLE 229. EUROPEAN UNION MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 230. EUROPEAN UNION MEMBRANE OXYGENATORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 231. BRICS MEMBRANE OXYGENATORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 232. BRICS MEMBRANE OXYGENATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 233. BRICS MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS OXYGENATORS, 2018-2032 (USD MILLION)
  • TABLE 234. BRICS MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL LIFE SUPPORT OXYGENATORS, 2018-2032 (USD MILLION)
  • TABLE 235. BRICS MEMBRANE OXYGENATORS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 236. BRICS MEMBRANE OXYGENATORS MARKET SIZE, BY FLOW CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 237. BRICS MEMBRANE OXYGENATORS MARKET SIZE, BY TEMPERATURE, 2018-2032 (USD MILLION)
  • TABLE 238. BRICS MEMBRANE OXYGENATORS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 239. BRICS MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 240. BRICS MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, 2018-2032 (USD MILLION)
  • TABLE 241. BRICS MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 242. BRICS MEMBRANE OXYGENATORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 243. G7 MEMBRANE OXYGENATORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 244. G7 MEMBRANE OXYGENATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 245. G7 MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS OXYGENATORS, 2018-2032 (USD MILLION)
  • TABLE 246. G7 MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL LIFE SUPPORT OXYGENATORS, 2018-2032 (USD MILLION)
  • TABLE 247. G7 MEMBRANE OXYGENATORS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 248. G7 MEMBRANE OXYGENATORS MARKET SIZE, BY FLOW CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 249. G7 MEMBRANE OXYGENATORS MARKET SIZE, BY TEMPERATURE, 2018-2032 (USD MILLION)
  • TABLE 250. G7 MEMBRANE OXYGENATORS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 251. G7 MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 252. G7 MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, 2018-2032 (USD MILLION)
  • TABLE 253. G7 MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 254. G7 MEMBRANE OXYGENATORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 255. NATO MEMBRANE OXYGENATORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 256. NATO MEMBRANE OXYGENATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 257. NATO MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS OXYGENATORS, 2018-2032 (USD MILLION)
  • TABLE 258. NATO MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL LIFE SUPPORT OXYGENATORS, 2018-2032 (USD MILLION)
  • TABLE 259. NATO MEMBRANE OXYGENATORS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 260. NATO MEMBRANE OXYGENATORS MARKET SIZE, BY FLOW CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 261. NATO MEMBRANE OXYGENATORS MARKET SIZE, BY TEMPERATURE, 2018-2032 (USD MILLION)
  • TABLE 262. NATO MEMBRANE OXYGENATORS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 263. NATO MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 264. NATO MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, 2018-2032 (USD MILLION)
  • TABLE 265. NATO MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 266. NATO MEMBRANE OXYGENATORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 267. GLOBAL MEMBRANE OXYGENATORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 268. UNITED STATES MEMBRANE OXYGENATORS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 269. UNITED STATES MEMBRANE OXYGENATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 270. UNITED STATES MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS OXYGENATORS, 2018-2032 (USD MILLION)
  • TABLE 271. UNITED STATES MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL LIFE SUPPORT OXYGENATORS, 2018-2032 (USD MILLION)
  • TABLE 272. UNITED STATES MEMBRANE OXYGENATORS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 273. UNITED STATES MEMBRANE OXYGENATORS MARKET SIZE, BY FLOW CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 274. UNITED STATES MEMBRANE OXYGENATORS MARKET SIZE, BY TEMPERATURE, 2018-2032 (USD MILLION)
  • TABLE 275. UNITED STATES MEMBRANE OXYGENATORS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 276. UNITED STATES MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 277. UNITED STATES MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, 2018-2032 (USD MILLION)
  • TABLE 278. UNITED STATES MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 279. UNITED STATES MEMBRANE OXYGENATORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 280. CHINA MEMBRANE OXYGENATORS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 281. CHINA MEMBRANE OXYGENATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 282. CHINA MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS OXYGENATORS, 2018-2032 (USD MILLION)
  • TABLE 283. CHINA MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL LIFE SUPPORT OXYGENATORS, 2018-2032 (USD MILLION)
  • TABLE 284. CHINA MEMBRANE OXYGENATORS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 285. CHINA MEMBRANE OXYGENATORS MARKET SIZE, BY FLOW CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 286. CHINA MEMBRANE OXYGENATORS MARKET SIZE, BY TEMPERATURE, 2018-2032 (USD MILLION)
  • TABLE 287. CHINA MEMBRANE OXYGENATORS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 288. CHINA MEMBRANE OXYGENATORS MARKET SIZE, BY BLOOD OXYGENATION FOR RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 289. CHINA MEMBRANE OXYGENATORS MARKET SIZE, BY CARDIOPULMONARY BYPASS, 2018-2032 (USD MILLION)
  • TABLE 290. CHINA MEMBRANE OXYGENATORS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 291. CHINA MEMBRANE OXYGENATORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)